IngredientesGentiana macrophylla, conocida en la Medicina Tradicional China (TCM) como Qin Jiao (秦艽), es una hierba perenne nativa de las regiones de gran altitud de China, Mongolia y Asia Central. A diferencia de Gentiana lutea, que es famosa por su amargor digestivo, Gentiana macrophylla se utiliza principalmente por sus propiedades antiinflamatorias y reumáticas. La raÃz seca es la parte medicinal, y contiene constituyentes clave como gentiopicróside, gentisina, swertiamarina y varios glucósidos iridoides, que contribuyen a sus efectos hepatoprotectores, antiinflamatorios, analgésicos e inmunomoduladores.
En la medicina herbal e integrativa moderna, Gentiana macrophylla se utiliza para aliviar el dolor articular y muscular, reducir la inflamación y apoyar la función hepática. Se emplea comúnmente en fórmulas para la artritis, el reumatismo, la ciática, la neuralgia y el dolor articular relacionado con enfermedades autoinmunes. La investigación también ha demostrado un potencial de actividad hepatoprotectora, que posiblemente ayuda a proteger el hÃgado del daño quÃmico o la inflamación.
A diferencia de la intensamente amarga Gentiana lutea, G. macrophylla tiene un sabor más suave y se utiliza tÃpicamente en decocciones, cápsulas o fórmulas patentadas. A menudo se combina con hierbas como fang feng (siler), dang gui (angélica) y bai shao (peonÃa blanca) en fórmulas tradicionales diseñadas para aliviar el viento-humedad y nutrir la sangre.
Uso Histórico
Gentiana macrophylla ha sido un elemento fundamental en la Medicina Tradicional China durante más de 1,000 años, con documentación que se remonta a textos médicos clásicos como el Shennong Bencao Jing. En la teorÃa de la TCM, Qin Jiao es amargo, acre y de naturaleza ligeramente frÃa, y penetra en los meridianos del Estómago, el HÃgado y la VesÃcula Biliar. Se utiliza tradicionalmente para disipar el viento-humedad, relajar los tendones y aliviar el dolor, particularmente en casos donde está presente la artritis de tipo caliente o la obstrucción dolorosa (sÃndrome Bi).
Qin Jiao también se utilizaba para reducir las fiebres maréales y el trastorno de huesos humeantes, ambos términos utilizados en la TCM para describir fiebres de bajo grado y sudores nocturnos frecuentemente asociados con la deficiencia de yin o la inflamación crónica. Además, a veces se aplicaba para tratar la ictericia y el estancamiento del Qi hepático, lo que indica su apoyo hepatobiliar más amplio.
En la medicina tibetana y mongola, las especies de genciana relacionadas también se utilizaban para la desintoxicación hepática, el dolor óseo y el apoyo digestivo, aunque en marcos energéticos ligeramente diferentes. Estas tradiciones enfatizaban de manera similar la naturaleza refrescante y desintoxicante de la hierba y su capacidad para aliviar las condiciones inflamatorias.
Hoy en dÃa, Gentiana macrophylla sigue siendo una hierba clave en las fórmulas herbales del Este Asiático para el dolor articular, la salud hepática y los sÃndromes inflamatorios, ofreciendo un perfil integral que une la sabidurÃa tradicional con la validación farmacológica moderna. Es una especie de genciana apreciada menos por su amargor y más por sus efectos calmantes, antiinflamatorios y restauradores.
Condiciones de salud que Gardenia jasminoides puede ayudar a apoyar.
Gardenia jasminoides extracts, particularly crocin and geniposide, have demonstrated potent antioxidant activity in multiple in vitro and in vivo studies including free radical scavenging, SOD restoration, and lipid peroxidation inhibition. Genipin is described as a specific hydroxyl radical scavenger. An in vitro antioxidant study of GJ fruit extracts was published in Food Chemistry (2011).
Fructus Gardeniae (FG) has demonstrated anxiolytic-like effects in preclinical rodent models, primarily by modulating neuroinflammation and gut-brain axis signaling. In a rat model of sleep-deprivation-induced anxiety, FG reduced pro-inflammatory cytokines (TNF-α, IL-1β) in the hippocampus and restored gut microbiota balance, correlating with reduced anxiety-like behavior in open-field and elevated plus-maze tests. Human clinical evidence remains absent.
Geniposide from Gardenia jasminoides has demonstrated anti-arthritic effects in adjuvant-induced arthritis rat models, suppressing synoviocyte hyperpermeability via RhoA/p38MAPK/NF-κB/F-actin pathways and reducing joint inflammatory cell infiltration. Anti-osteoporosis effects relevant to bone-joint health have also been identified. Evidence is preclinical.
Geniposide from Gardenia jasminoides has demonstrated antithrombotic activity and inhibition of platelet aggregation in preclinical studies, as documented in multiple pharmacological reviews. This is listed among geniposide's established pharmacological activities in peer-reviewed literature. Human clinical evidence is absent.
Gardenia jasminoides demonstrated antihypertensive effects in an L-NNA-induced hypertension mouse model, with geniposide identified as the primary active component. GJ-treated mice showed significantly lower systolic, diastolic, and mean blood pressure vs. controls. A 2025 human study also showed gardenia floral volatiles reduced blood pressure and pulse in college students.
Multiple preclinical studies demonstrate that Gardenia jasminoides and its active components geniposide and crocin I exert hypoglycemic effects in type 2 diabetic animal models. Mechanisms include UCP2 inhibition by genipin (stimulating pancreatic beta-cell insulin secretion), GLP-1 receptor agonism by geniposide, and reduced oxidative stress in islet cells. No human clinical trials have confirmed these effects.
A 2025 human study published in Scientific Reports found that the floral volatiles of Gardenia jasminoides (rich in terpenes and linalool) measurably reduced physiological stress markers in college students, including increased alpha-wave power and reduced beta-wave power. These compounds are associated with nervous system regulation and sedative effects. The study was controlled but limited in scope.
A glycoprotein isolated from Gardenia jasminoides reduced plasma total cholesterol, triglycerides, and LDL in mice (Clin Exp Pharmacol Physiol, 2006). Crocin inhibits pancreatic lipase activity in vitro to reduce lipid absorption. These hypolipidemic effects have been identified as relevant to TCM's traditional use of Fructus Gardeniae in metabolic conditions.
Genipin and geniposide from Gardenia jasminoides have been well characterized as anti-inflammatory agents in multiple preclinical models, acting by suppressing NF-κB, MAPK, and AP-1 signaling pathways and inhibiting pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, NO). These effects have been documented across carrageenan-induced edema, LPS-induced macrophage activation, colitis, arthritis, and pancreatitis models. Human data are lacking.
Gardenia jasminoides extracts (crocin-rich GJ-4) protected against cognitive decline in APP/PS1 transgenic Alzheimer's disease mice over 12 weeks of oral treatment. Genipin and crocin also protect against age-related neurodegeneration via anti-inflammatory, antioxidant, and tau-phosphorylation-reducing mechanisms. Evidence is from animal models of neurodegeneration.
Crocin and the iridoid fraction of Gardenia jasminoides have demonstrated antidepressant-like effects in multiple preclinical rodent models of depression (CUMS, forced-swim, tail-suspension tests) via PKA-CREB signaling pathway activation and modulation of the HPA axis. Geniposide has also shown antidepressant activity in chronic unpredictable mild stress models. No human RCTs have been completed.
Gardenia jasminoides extract has shown efficacy against atopic dermatitis (eczema) in multiple mouse models via inhibition of Th2-mediated inflammatory responses, suppression of IgE and histamine, and restoration of skin barrier proteins. Geniposide is identified as a key active constituent for these anti-allergic effects. Evidence remains preclinical.
Gardenia jasminoides (Fructus Gardeniae) has been used for millennia in TCM as a primary antipyretic herb. Modern pharmacological evidence shows geniposide exerts antipyretic effects in febrile rats by modulating the TLR4/NF-κB signaling pathway, a mechanism published in the Journal of Ethnopharmacology (2024). The antipyretic mechanism has also been explored via plasma metabolomics in yeast-induced fever rat models.
Gardenia jasminoides is a core component of the classical TCM formula Yinchenhaotang, prescribed for cholestatic liver and gallbladder disorders. Geniposide and crocins promote bile flow (choleretic effect) and protect against bile acid-induced liver and bile duct injury in animal models. Traditional and preclinical scientific evidence is strong; human clinical data is mainly for the multi-herb formula.
Gardenia jasminoides (as part of Yinchenhaotang and as a standalone extract) has demonstrated choleretic (bile-flow promoting) effects and protection against bile acid-induced cholestasis and bile duct injury in animal models. Geniposide and crocins promote biliary secretion in rats. The formula containing gardenia is officially used clinically in Japan and China for cholestatic disorders.
Gardenia jasminoides fruit extract (GJE) has shown gastroprotective effects against both NSAID-induced gastropathy and H. pylori-induced gastritis in rat models, by inhibiting NF-κB and iNOS signaling, restoring prostaglandin E2 and mucin expression, and reducing bacterial growth and mucosal inflammation. Evidence is preclinical; human clinical studies have not been completed.
Gardeniae fructus (Gardenia jasminoides fruit) demonstrated significantly greater GLP-1 secretion than positive control EGCG in an in vitro assay. Two of its ligands—3-epioleanolic acid and crocin—were predicted to bind to the active GLP-1 receptor, suggesting potential as GLP-1 receptor agonists.
Geniposide from Gardenia jasminoides is metabolized by intestinal bacteria into genipin, making the gut microbiome central to its bioavailability and pharmacological activity. GJE has been shown to modulate gut microbiota composition in T2DM and sleep-deprivation models, and to protect intestinal mucosal integrity by upregulating tight junction proteins and suppressing pro-inflammatory cytokines. These are preclinical findings.
Geniposide from Gardenia jasminoides has been shown to protect against myocardial dysfunction and ischemia-reperfusion injury in preclinical models, via anti-inflammatory, anti-apoptotic, and antioxidant mechanisms. A 2022 PMC review (Molecules) identified 'anti-myocardial dysfunction effect' among geniposide's confirmed pharmacological activities. Evidence is entirely preclinical.
A double-blind, placebo-controlled, crossover clinical trial of 21 healthy adult men found that crocetin (a carotenoid from Gardenia jasminoides) reduced the number of wakening episodes as measured by actigraph (p=0.025) over 2 weeks. Geniposide and gardenoside have also shown sedative properties in animal models. This is the primary human evidence for this indication.
Genipin from Gardenia jasminoides inhibits UCP2 in pancreatic beta cells, reversing obesity- and high-glucose-induced insulin secretion dysfunction. Geniposide acts as a GLP-1 receptor agonist to enhance glucose-dependent insulin release. In aged rats, genipin administration significantly reduced hyperinsulinemia and hyperglycemia. These are preclinical mechanistic findings.
Gardenia jasminoides has extensive preclinical evidence for hepatoprotective and cholagogic (bile-promoting) effects. Key constituents geniposide and crocins protect against chemical-induced liver injury (CCl4, ANIT, acetaminophen, alcohol), reduce ALT/AST enzyme elevations, and promote bile flow. It is a core herb in the TCM liver-jaundice formula Yinchenhaotang, which has clinical use in Japan and China.
Gardenia jasminoides extracts (particularly crocin-rich fractions) have reversed memory loss in Drosophila and mouse Alzheimer's disease models. Crocin from gardenia protects hippocampal neurons from oxidative damage, modulates MAPK to suppress tau phosphorylation, and reduces neuroinflammation—effects linked to improved spatial cognitive performance in rodents. Evidence is preclinical.
Gardenia jasminoides and its constituents have been studied in high-fat diet rodent models of metabolic syndrome, demonstrating effects on blood glucose, blood lipids (triglycerides, cholesterol), and gut microbiota remodeling. A 2024 PMC study demonstrated attenuation of glycolipid metabolism disorder in HFD rats via gut microbiota targeting and TLR4/Myd88/NF-κB pathway. Evidence is preclinical.
Gardenia jasminoides was shown to protect against cerulein-induced acute pancreatitis in mice (C57BL/6), significantly reducing pancreatic edema, amylase/lipase levels, and lung injury in a dose-dependent manner. Geniposide has also been identified as a promising therapeutic for acute pancreatitis by ameliorating acinar cell injury and oxidative stress. Evidence is preclinical.
Geniposide and genipin from Gardenia jasminoides have demonstrated neuroprotective effects against dopaminergic neuron loss in MPTP-induced Parkinson's disease mouse models, mediated by anti-inflammatory and anti-apoptotic mechanisms. Crocin reversed depression-like behavior in a PD mouse model via VTA-mPFC dopaminergic pathway modulation. Evidence is entirely preclinical.
Gardenia jasminoides extract and geniposide have demonstrated anti-allergic activity relevant to urticaria (hives) and inflammatory skin reactions, primarily by inhibiting histamine release from mast cells and suppressing IgE and Th2 cytokines. These effects have been confirmed in mast cell lines and multiple AD mouse models. Evidence is preclinical.
Geniposide from Gardenia jasminoides demonstrated anti-rheumatic activity in adjuvant-induced arthritis rat models, inhibiting synoviocyte hyperpermeability via RhoA/p38MAPK/NF-κB/F-actin signaling and reducing paw swelling and synovial inflammation. It is listed in preclinical literature as a therapeutic candidate for rheumatoid arthritis alongside IBD and neurodegenerative disorders.
A double-blind, placebo-controlled clinical trial in 40 female volunteers found that a Gardenia jasminoides extract stabilized in Natural Deep Eutectic Solvent (NaDES) acted as a blue light filter and melatonin-like ingredient, reducing digital-stress-induced skin aging signs. Crocin within the extract also has documented antioxidant and anti-inflammatory effects on human keratinocytes and fibroblasts relevant to photoaging.
A double-blind, placebo-controlled crossover human trial showed that crocetin from Gardenia jasminoides reduced nighttime wakening episodes (objective actigraph, p=0.025) in men with mild sleep complaints over 2 weeks. Preclinical studies additionally show modulation of gut microbiota by GJE correlates with improved sleep quality metrics in rodents.
A 2025 human study (Scientific Reports) found that Gardenia jasminoides floral volatiles reduced physiological stress markers in college students—specifically decreasing beta-wave power, skin electrical signal, and blood pressure, while increasing alpha-wave power and HRV. Preclinically, gardenia modulates the HPA axis stress response and reduces hippocampal neuroinflammation in stress models.
A glycoprotein from Gardenia jasminoides reduced plasma triglycerides in mice (Clin Exp Pharmacol Physiol, 2006). Geniposide has been confirmed to regulate blood lipids in multiple preclinical studies, and gardenia extract reduced triglycerides and lipid peroxidation in high-fat diet rodent metabolic models. Evidence is preclinical.
Gardenia jasminoides fruit extract (GJE) protected against NSAID-induced gastric ulcers in rats by restoring the cytoprotective factors PGE2 and MUC5AC and suppressing iNOS and NF-κB. Geniposide also protects gastric mucosa and is formally listed among geniposide's therapeutic activities. Evidence is from animal models.
Fructus Gardeniae is documented in TCM for abdominal pain and discomfort associated with heat and dampness patterns, including 'blood strangury with astringent pain.' The Chinese Pharmacopoeia formally records this indication. Geniposide has demonstrated analgesic effects in preclinical writhing tests, providing some mechanistic support.
Fructus Gardeniae is documented in classical TCM texts and modern ethnopharmacological reviews as a traditional treatment for headaches, typically attributed to 'liver fire rising.' This use is recorded in the Shennong Bencao Jing and subsequent materia medica. No clinical trials have been conducted specifically for headache.
Fructus Gardeniae is documented in TCM for 'eliminating vexation' and treating stomach upset and nausea associated with heat conditions. It is included in TCM formulas such as Zhi-zi-chi decoction for vomiting and restlessness. Preclinical evidence for gastric motility or anti-emetic effects is limited; no human clinical trials specifically address nausea/vomiting.
Gardenia jasminoides is traditionally used in TCM formulas for insomnia, including Zhi-zi-chi decoction, for difficulty falling asleep associated with heart fire and restlessness. Preclinical evidence shows geniposide and gardenoside have sedative properties in animal models. The 2010 crocetin human trial did not measure sleep onset latency specifically.
Fructus Gardeniae is documented in the Chinese Pharmacopoeia for external application to treat 'writhing and contusion pain,' which encompasses sprains and soft tissue injuries. This is a well-established traditional use in TCM supported by its anti-inflammatory and analgesic properties, though no clinical trials specifically for sprains exist.
Fructus Gardeniae is documented in the Chinese Pharmacopoeia for external use on 'fire toxin sores and sores' and contusion pain, representing traditional wound healing use. Genipin, a crosslinking agent derived from geniposide, has been studied as a biomaterial crosslinker relevant to wound healing but not as a direct oral/topical therapeutic in wound healing RCTs.
Sistemas corporales que Gardenia jasminoides puede ayudar a apoyar.
Volver